CVRX MEXC RealStocks
Own real CVRX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 12:34:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
CVRx, Inc. (CVRX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalization of $17.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.61 to $10.28. This page covers its latest market performance, valuation, price trends and company information.
$17.95M | |
$0.65 | |
$0.72 | |
$0.61 | |
$0.63 | |
2.92K | |
749.61K | |
-- | |
$10.28 | |
$0.61 | |
-- | |
-- |
CVRx, Inc. (CVRX) is trading at $0.65 in pre-market trading as of 2026-11-13 12:25:00, up 2.36% ($0.01) from the previous close of $0.63
Pre-market trading shows how investors are pricing CVRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, CVRx, Inc. (CVRX) moved from $1.47 to $0.65, representing a decline of 56.12% ($0.83).
The stock traded between $0.61 and $1.56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.61 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.3%
CVRX is currently trading at $0.65, placing it 0.3% of the way from its 52-week low of $0.61 to its 52-week high of $10.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 223 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CVRx, Inc. (CVRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CVRX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CVRX shares and USD.
CVRX Shares to USD
1.00 CVRX shares = 0.645 USD
Calculations are estimates based on the latest available price and are for reference only.